The data showed that silencing LRRC56 expression in BC cells decreased protein expression of key RhoA/ROCKs pathway components, while overexpression of LRRC56 increased these protein levels (Fig. 3a, Fig. S1a-d). Here, RHOA is linked to breast cancer.